Predictors of benefit following pulmonary rehabilitation for interstitial lung disease

Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitati...

Full description

Saved in:
Bibliographic Details
Published inRespiratory medicine Vol. 106; no. 3; pp. 429 - 435
Main Authors Holland, Anne E., Hill, Catherine J., Glaspole, Ian, Goh, Nicole, McDonald, Christine F.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.03.2012
Elsevier
Elsevier Limited
Subjects
ILD
CRQ
ROC
MID
FVC
IPF
Online AccessGet full text
ISSN0954-6111
1532-3064
1532-3064
DOI10.1016/j.rmed.2011.11.014

Cover

Abstract Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity ( r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation ( r S = 0.43, p = 0.04) and lower right ventricular systolic pressure ( r = −0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.
AbstractList Summary Background Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Methods Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. Results In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity ( r  = 0.49, p  = 0.01), less exercise-induced oxyhaemoglobin desaturation ( rS  = 0.43, p  = 0.04) and lower right ventricular systolic pressure ( r  = −0.47, p  = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p  = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Conclusions Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.
Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation.BACKGROUNDPulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation.Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion.METHODSForty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion.In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r(S) = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months.RESULTSIn IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r(S) = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months.Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.CONCLUSIONSPatients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.
Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r S = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. 30 references
Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r S = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.
Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity ( r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation ( r S = 0.43, p = 0.04) and lower right ventricular systolic pressure ( r = −0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.
Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r(S) = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.
Author Goh, Nicole
Holland, Anne E.
Glaspole, Ian
McDonald, Christine F.
Hill, Catherine J.
Author_xml – sequence: 1
  givenname: Anne E.
  surname: Holland
  fullname: Holland, Anne E.
  email: a.holland@alfred.org.au
  organization: Physiotherapy, Alfred Health, VIC 3004, Australia
– sequence: 2
  givenname: Catherine J.
  surname: Hill
  fullname: Hill, Catherine J.
  organization: Institute for Breathing and Sleep, VIC 3084, Australia
– sequence: 3
  givenname: Ian
  surname: Glaspole
  fullname: Glaspole, Ian
  organization: Allergy, Immunology and Respiratory Medicine, Alfred Health, VIC 3004, Australia
– sequence: 4
  givenname: Nicole
  surname: Goh
  fullname: Goh, Nicole
  organization: Institute for Breathing and Sleep, VIC 3084, Australia
– sequence: 5
  givenname: Christine F.
  surname: McDonald
  fullname: McDonald, Christine F.
  organization: Institute for Breathing and Sleep, VIC 3084, Australia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25572644$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22182340$$D View this record in MEDLINE/PubMed
BookMark eNqNkluLFDEQhYOsuLOrf8AHaRDRlx6TdCfpXkSQxRssKHh5DZl0tWbMJGOSVvbfW83MsjDgKBTk5TtVqTrnjJyEGICQh4wuGWXy-XqZNjAsOWVsiUVZe4csmGh43VDZnpAF7UVbS8bYKTnLeU0p7duW3iOnnLOONy1dkK8fEwzOlphyFcdqBQFGV6oxeh9_u_Ct2k5-E4NJ11WC72blvCumuBgQSZULBVIurjjjKz8hPrgMJsN9cnc0PsOD_XtOvrx5_fnyXX314e37y1dXtZW9KDUXK2AryzvBRwpMqd5KwD8CkwDMNkPXdIp2HSglRwuNHGDgUlEj5GAlb5pz8nTXd5vizwly0RuXLXhvAsQp655J2aOAIvnsKMnmYwnOufoPlKu-E4rN6OMDdB2nFHBlpBrBGiUFR-rRnppW6JjeJrfBi-obGxB4sgdMtsaPyQTr8i0nhOKybZHrdpxNMecEo7Z7O0oyzuNMPSdDr_WcDD0nQ2NhMlDKD6Q33Y-KXuxEgB7-cpB0tg6CxcgksEUP0R2XvzyQW--Cww1_wDXk21PpzDXVn2YL5rgyRmnbCIENLv7e4F_T_wDbI_g0
CitedBy_id crossref_primary_10_1513_AnnalsATS_202306_561OC
crossref_primary_10_1016_j_rmr_2017_07_017
crossref_primary_10_1016_j_rmr_2017_07_018
crossref_primary_10_1016_j_arbres_2013_03_011
crossref_primary_10_1080_17476348_2018_1472580
crossref_primary_10_1097_MCP_0b013e328363f4cb
crossref_primary_10_1183_16000617_0220_2021
crossref_primary_10_1590_S1806_37132013000300012
crossref_primary_10_1016_j_rmed_2013_11_016
crossref_primary_10_1177_1753465816676048
crossref_primary_10_1298_ptr_R0012
crossref_primary_10_15446_revfacmed_v66n3_63970
crossref_primary_10_1016_j_rmr_2022_01_014
crossref_primary_10_1517_14728214_2015_1102886
crossref_primary_10_1183_16000617_0065_2019
crossref_primary_10_1080_17476348_2016_1227244
crossref_primary_10_1186_s12931_018_0884_y
crossref_primary_10_1080_21679169_2019_1578826
crossref_primary_10_1183_23120541_00245_2018
crossref_primary_10_23736_S1973_9087_18_05093_1
crossref_primary_10_1183_23120541_00107_2020
crossref_primary_10_1183_16000617_0092_2023
crossref_primary_10_1586_17476348_2016_1121104
crossref_primary_10_5694_mja17_00799
crossref_primary_10_1097_HCR_0b013e31828db112
crossref_primary_10_1016_j_opresp_2021_100100
crossref_primary_10_3390_jcm10143153
crossref_primary_10_4103_ecdt_ecdt_66_22
crossref_primary_10_3390_healthcare11111593
crossref_primary_10_1016_j_pneumo_2013_12_004
crossref_primary_10_3233_IES_210123
crossref_primary_10_1183_20734735_006916
crossref_primary_10_3233_THC_240285
crossref_primary_10_1186_s12890_017_0476_5
crossref_primary_10_1016_j_arbr_2013_06_003
crossref_primary_10_1080_09593985_2023_2245878
crossref_primary_10_1097_HCR_0000000000000338
crossref_primary_10_12968_ijpn_2012_18_7_331
crossref_primary_10_2490_jjrmc_60_102
crossref_primary_10_1097_HCR_0b013e3182839293
crossref_primary_10_1177_14799731211046022
crossref_primary_10_57224_jhpr_1072917
crossref_primary_10_3390_life13020506
crossref_primary_10_1183_09059180_00005613
crossref_primary_10_1111_resp_13146
crossref_primary_10_1111_resp_12650
crossref_primary_10_1159_000370126
crossref_primary_10_1097_HCR_0000000000000083
crossref_primary_10_1177_09733698241310941
crossref_primary_10_1016_j_resmer_2022_100948
crossref_primary_10_1016_j_rmed_2020_106184
crossref_primary_10_1016_j_rmr_2013_09_007
crossref_primary_10_1183_23120541_00591_2023
crossref_primary_10_4187_respcare_02520
crossref_primary_10_3390_arm90050052
crossref_primary_10_1159_000354112
crossref_primary_10_1080_17476348_2020_1776118
crossref_primary_10_1159_000517030
crossref_primary_10_1093_qjmed_hcw105
crossref_primary_10_1111_imj_13078
crossref_primary_10_1513_AnnalsATS_201703_244FR
crossref_primary_10_1093_fampra_cmw077
crossref_primary_10_1007_s10067_019_04717_9
crossref_primary_10_1016_j_ft_2014_12_001
crossref_primary_10_1080_21679169_2023_2287511
crossref_primary_10_15406_ipmrj_2017_02_00063
crossref_primary_10_4103_jalh_jalh_5_24
crossref_primary_10_1136_thoraxjnl_2016_208638
crossref_primary_10_1016_j_rmed_2014_03_008
crossref_primary_10_3390_ijerph18147643
crossref_primary_10_4081_mrm_2020_707
crossref_primary_10_1186_1471_2466_13_8
crossref_primary_10_2174_1389557523666230816090112
crossref_primary_10_1016_j_lpm_2023_104166
crossref_primary_10_3389_fmed_2022_917973
crossref_primary_10_1080_24745332_2018_1503456
crossref_primary_10_1177_1753465816686743
crossref_primary_10_1089_respcare_11712
crossref_primary_10_1097_MCP_0b013e3283541337
crossref_primary_10_1016_j_ccm_2014_02_016
crossref_primary_10_31189_2165_7629_9_2_67
crossref_primary_10_3390_jcm9051567
crossref_primary_10_1097_HCR_0000000000000315
crossref_primary_10_1111_resp_12649
crossref_primary_10_1007_s13665_012_0031_z
crossref_primary_10_1016_j_ft_2022_01_001
crossref_primary_10_1097_HCR_0000000000000275
crossref_primary_10_4103_ejb_ejb_64_18
Cites_doi 10.1016/j.rmed.2009.04.024
10.1164/rccm.200508-1211ST
10.1136/thx.2007.088070
10.1164/rccm.2009-040GL
10.1378/chest.09-0241
10.1002/14651858.CD006322.pub2
10.1164/rccm.200302-219OC
10.1037/0022-3514.51.6.1173
10.1002/14651858.CD003793.pub2
10.1016/j.rmed.2007.03.012
10.1183/09031936.93.01060510
10.1378/chest.06-1466
10.1378/chest.08-1458
10.1111/j.1440-1843.2007.01205.x
10.1164/rccm.200604-488OC
10.1164/rccm.2111053
10.1148/radiol.2321030392
10.1016/j.rmed.2008.08.014
10.1097/00063198-199809000-00006
10.1111/j.1440-1843.2011.02029.x
10.1136/thx.43.9.708
10.1378/chest.116.5.1175
10.1183/09031936.04.00137203
10.1164/ajrccm.166.1.at1102
10.1136/oem.60.3.201
10.1136/thx.2008.101691
10.1016/0197-2456(89)90005-6
10.1164/ajrccm.161.2.ats3-00
10.1159/000315475
ContentType Journal Article
Copyright 2011 Elsevier Ltd
Elsevier Ltd
2015 INIST-CNRS
Copyright © 2011 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2011 Elsevier Ltd
– notice: Elsevier Ltd
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 Elsevier Ltd. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U9
ASE
FPQ
H94
K6X
K9.
M7N
NAPCQ
7X8
DOI 10.1016/j.rmed.2011.11.014
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Virology and AIDS Abstracts
British Nursing Index
British Nursing Index (BNI) (1985 to Present)
AIDS and Cancer Research Abstracts
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
British Nursing Index
Virology and AIDS Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
British Nursing Index
AIDS and Cancer Research Abstracts


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-3064
EndPage 435
ExternalDocumentID 2745518681
22182340
25572644
10_1016_j_rmed_2011_11_014
S0954611111004355
1_s2_0_S0954611111004355
Genre Evaluation Studies
Journal Article
GeographicLocations Australia
GeographicLocations_xml – name: Australia
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29P
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
BKEYQ
BKOJK
BLXMC
BNPGV
BNQBC
BPHCQ
BVXVI
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMK
HMO
HVGLF
HZ~
IHE
IXB
J1W
K-O
KOM
L7B
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OI-
OK1
OU.
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
RSU
SAE
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
SV3
T5K
UHS
UV1
WH7
WOW
WUQ
X7M
Z5R
ZGI
ZXP
~G-
0SF
3V.
6I.
7RV
7X7
AACTN
AAFTH
ABVKL
AFCTW
AFKRA
AFKWA
AJOXV
AMFUW
BENPR
M0T
M2O
NCXOZ
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
CITATION
AGRNS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U9
ASE
FPQ
H94
K6X
K9.
M7N
NAPCQ
7X8
ID FETCH-LOGICAL-c695t-25be1bc2852f0e1779c6e944e16ee1c3d8387088e776fce36ded2670a56dc6233
IEDL.DBID IXB
ISSN 0954-6111
1532-3064
IngestDate Thu Sep 04 21:03:24 EDT 2025
Fri Sep 05 09:23:00 EDT 2025
Thu Sep 04 17:59:01 EDT 2025
Sat Aug 23 12:35:30 EDT 2025
Thu Apr 03 06:58:23 EDT 2025
Mon Jul 21 09:16:24 EDT 2025
Sun Aug 31 07:19:50 EDT 2025
Thu Apr 24 22:51:35 EDT 2025
Fri Feb 23 02:31:39 EST 2024
Sun Feb 23 10:19:34 EST 2025
Tue Aug 26 19:58:24 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords ILD
SpO 2
CRQ
Lung diseases
ROC
RVSP
MID
Dyspnoea
FVC
Pulmonary fibrosis
Exercise
DLCO
Interstitial
6MWD
IPF
forced vital capacity
right ventricular systolic pressure
interstitial lung disease
oxyhaemoglobin saturation measured by pulse oximetry
receiver operating characteristic
idiopathic pulmonary fibrosis
6-minute walk distance
diffusing capacity for carbon monoxide
minimal important difference
Chronic Respiratory Questionnaire
Physical exercise
Lung disease
Respiratory disease
Interstitial pneumonitis
Rehabilitation
Predictive factor
Pneumology
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
https://www.elsevier.com/open-access/userlicense/1.0
CC BY 4.0
Copyright © 2011 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c695t-25be1bc2852f0e1779c6e944e16ee1c3d8387088e776fce36ded2670a56dc6233
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Undefined-1
ObjectType-Feature-3
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0954611111004355
PMID 22182340
PQID 1035137652
PQPubID 1216389
PageCount 7
ParticipantIDs proquest_miscellaneous_916696700
proquest_miscellaneous_1095452227
proquest_miscellaneous_1027985717
proquest_journals_1035137652
pubmed_primary_22182340
pascalfrancis_primary_25572644
crossref_citationtrail_10_1016_j_rmed_2011_11_014
crossref_primary_10_1016_j_rmed_2011_11_014
elsevier_sciencedirect_doi_10_1016_j_rmed_2011_11_014
elsevier_clinicalkeyesjournals_1_s2_0_S0954611111004355
elsevier_clinicalkey_doi_10_1016_j_rmed_2011_11_014
PublicationCentury 2000
PublicationDate 2012-03-01
PublicationDateYYYYMMDD 2012-03-01
PublicationDate_xml – month: 03
  year: 2012
  text: 2012-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: England
– name: Oxford
PublicationTitle Respiratory medicine
PublicationTitleAlternate Respir Med
PublicationYear 2012
Publisher Elsevier Ltd
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
– name: Elsevier Limited
References Lee, Singh, Pang, de Klerk, Hillman, Musk (bib7) 2003; 60
Wells, Desai, Rubens, Goh, Cramer, Nicholson, Colby, du Bois, Hansell (bib18) 2003; 167
Holland, Hill (bib5) 2008
Hamada, Nagai, Tanaka, Handa, Shigematsu, Nagao, Mishima, Kitaichi, Izumi (bib19) 2007; 131
Markos, Musk, Finucane (bib6) 1988; 43
Bradley, Branley, Egan, Greaves, Hansell, Harrison, Hirani, Hubbard, Lake, Millar, Wallace, Wells, Whyte, Wilsher (bib30) 2008; 63
Holland, Hill, Conron, Munro, McDonald (bib1) 2008; 63
Nici, Donner, Wouters, Zuwallack, Ambrosino, Bourbeau, Carone, Celli, Engelen, Fahy, Garvey, Goldstein, Gosselink, Lareau, MacIntyre, Maltais, Morgan, O’Donnell, Prefault, Reardon, Rochester, Schols, Singh, Troosters (bib29) 2006; 173
Hallstrand, Boitano, Johnson, Spada, Hayes, Raghu (bib15) 2005; 25
Lacasse, Goldstein, Lasserson, Martin (bib3) 2006
Swigris, Brown, Make, Wamboldt (bib10) 2008; 102
Jaeschke, Singer, Guyatt (bib17) 1989; 10
Baron, Kenny (bib27) 1986; 51
Sette, Neder, Nery, Kavakama, Rodrigues, Terra-Filho, Guimaraes, Bagatin, Muller (bib8) 2004; 232
Flaherty, Andrei, Murray, Fraley, Colby, Travis, Lama, Kazerooni, Gross, Toews, Martinez (bib20) 2006; 174
Lama, Flaherty, Toews, Colby, Travis, Long, Murray, Kazerooni, Gross, Lynch, Martinez (bib26) 2003; 168
Ferreira, Garvey, Connors, Hilling, Rigler, Farrell, Cayou, Shariat, Collard (bib21) 2009; 135
Bradley, Branley, Egan, Greaves, Hansell, Harrison, Hirani, Hubbard, Lake, Millar, Wallace, Wells, Whyte, Wilsher (bib9) 2008; 63
Idiopathic Pulmonary Fibrosis (bib12) 2000; 161
Chang, Curtis, Patrick, Raghu (bib16) 1999; 116
Collard, Loyd, King, Lancaster (bib4) 2007; 101
Holland, Hill, Conron, Munro, McDonald (bib13) 2009; 103
Kozu, Jenkins, Senjyu (bib24) 2011; 16
Kozu, Senjyu, Jenkins, Mukae, Sakamoto, Kohno (bib22) 2011; 81
Raghu, Collard, Egan, Martinez, Behr, Brown, Colby, Cordier, Flaherty, Lasky, Lynch, Ryu, Swigris, Wells, Ancochea, Bouros, Carvalho, Costabel, Ebina, Hansell, Johkoh, Kim, King, Kondoh, Myers, Muller, Nicholson, Richeldi, Selman, Dudden, Griss, Protzko, Schunemann (bib25) 2011; 183
Markovitz, Cooper (bib11) 1998; 4
Salhi, Troosters, Behaegel, Joos, Derom (bib23) 2010; 137
Nishiyama, Kondoh, Kimura, Kato, Kataoka, Ogawa, Watanabe, Arizono, Nishimura, Taniguchi (bib2) 2008; 13
(bib14) 2002; 166
Agusti, Roca, Rodriguez-Roisin, Xaubet, Agusti-Vidal (bib28) 1988; 1
Hallstrand (10.1016/j.rmed.2011.11.014_bib15) 2005; 25
Lacasse (10.1016/j.rmed.2011.11.014_bib3) 2006
Hamada (10.1016/j.rmed.2011.11.014_bib19) 2007; 131
Collard (10.1016/j.rmed.2011.11.014_bib4) 2007; 101
Idiopathic Pulmonary Fibrosis (10.1016/j.rmed.2011.11.014_bib12) 2000; 161
Ferreira (10.1016/j.rmed.2011.11.014_bib21) 2009; 135
Kozu (10.1016/j.rmed.2011.11.014_bib24) 2011; 16
Swigris (10.1016/j.rmed.2011.11.014_bib10) 2008; 102
Lama (10.1016/j.rmed.2011.11.014_bib26) 2003; 168
Wells (10.1016/j.rmed.2011.11.014_bib18) 2003; 167
Agusti (10.1016/j.rmed.2011.11.014_bib28) 1988; 1
Kozu (10.1016/j.rmed.2011.11.014_bib22) 2011; 81
Markovitz (10.1016/j.rmed.2011.11.014_bib11) 1998; 4
Nishiyama (10.1016/j.rmed.2011.11.014_bib2) 2008; 13
Bradley (10.1016/j.rmed.2011.11.014_bib9) 2008; 63
Chang (10.1016/j.rmed.2011.11.014_bib16) 1999; 116
Baron (10.1016/j.rmed.2011.11.014_bib27) 1986; 51
Holland (10.1016/j.rmed.2011.11.014_bib5) 2008
Markos (10.1016/j.rmed.2011.11.014_bib6) 1988; 43
Jaeschke (10.1016/j.rmed.2011.11.014_bib17) 1989; 10
Sette (10.1016/j.rmed.2011.11.014_bib8) 2004; 232
Nici (10.1016/j.rmed.2011.11.014_bib29) 2006; 173
Lee (10.1016/j.rmed.2011.11.014_bib7) 2003; 60
Bradley (10.1016/j.rmed.2011.11.014_bib30) 2008; 63
(10.1016/j.rmed.2011.11.014_bib14) 2002; 166
Holland (10.1016/j.rmed.2011.11.014_bib1) 2008; 63
Raghu (10.1016/j.rmed.2011.11.014_bib25) 2011; 183
Holland (10.1016/j.rmed.2011.11.014_bib13) 2009; 103
Salhi (10.1016/j.rmed.2011.11.014_bib23) 2010; 137
Flaherty (10.1016/j.rmed.2011.11.014_bib20) 2006; 174
References_xml – volume: 13
  start-page: 394
  year: 2008
  end-page: 399
  ident: bib2
  article-title: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
  publication-title: Respirology
– volume: 63
  start-page: v1
  year: 2008
  end-page: 58
  ident: bib30
  article-title: Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society
  publication-title: Thorax
– volume: 161
  start-page: 646
  year: 2000
  end-page: 664
  ident: bib12
  article-title: Diagnosis and treatment. International consensus statement
  publication-title: Am J Respir Crit Care Med
– volume: 168
  start-page: 1084
  year: 2003
  end-page: 1090
  ident: bib26
  article-title: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia
  publication-title: Am J Respir Crit Care Med
– volume: 166
  start-page: 111
  year: 2002
  end-page: 117
  ident: bib14
  article-title: ATS statement: guidelines for the six-minute walk test
  publication-title: Am J Respir Crit Care Med
– volume: 25
  start-page: 96
  year: 2005
  end-page: 103
  ident: bib15
  article-title: The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
  publication-title: Eur Respir J
– volume: 137
  start-page: 273
  year: 2010
  end-page: 279
  ident: bib23
  article-title: Effects of pulmonary rehabilitation in patients with restrictive lung diseases
  publication-title: Chest
– volume: 174
  start-page: 803
  year: 2006
  end-page: 809
  ident: bib20
  article-title: Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test
  publication-title: Am J Respir Crit Care Med
– volume: 135
  start-page: 442
  year: 2009
  end-page: 447
  ident: bib21
  article-title: Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response
  publication-title: Chest
– volume: 101
  start-page: 2011
  year: 2007
  end-page: 2016
  ident: bib4
  article-title: Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians
  publication-title: Respir Med
– volume: 167
  start-page: 962
  year: 2003
  end-page: 969
  ident: bib18
  article-title: Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography
  publication-title: Am J Respir Crit Care Med
– volume: 173
  start-page: 1390
  year: 2006
  end-page: 1413
  ident: bib29
  article-title: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
  publication-title: Am J Respir Crit Care Med
– volume: 63
  start-page: v1
  year: 2008
  end-page: 58
  ident: bib9
  article-title: Interstitial lung disease guideline
  publication-title: Thorax
– year: 2008
  ident: bib5
  article-title: Physical training for interstitial lung disease
  publication-title: Cochrane Database Syst Rev
– volume: 131
  start-page: 650
  year: 2007
  end-page: 656
  ident: bib19
  article-title: Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
  publication-title: Chest
– volume: 116
  start-page: 1175
  year: 1999
  end-page: 1182
  ident: bib16
  article-title: Assessment of health-related quality of life in patients with interstitial lung disease
  publication-title: Chest
– volume: 63
  start-page: 549
  year: 2008
  end-page: 554
  ident: bib1
  article-title: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease
  publication-title: Thorax
– volume: 183
  start-page: 788
  year: 2011
  end-page: 824
  ident: bib25
  article-title: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
  publication-title: Am J Respir Crit Care Med
– year: 2006
  ident: bib3
  article-title: Pulmonary rehabilitation for chronic obstructive pulmonary disease
  publication-title: Cochrane Database Syst Rev
– volume: 60
  start-page: 201
  year: 2003
  end-page: 206
  ident: bib7
  article-title: Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis
  publication-title: Occup Environ Med
– volume: 232
  start-page: 66
  year: 2004
  end-page: 74
  ident: bib8
  article-title: Thin-section CT abnormalities and pulmonary gas exchange impairment in workers exposed to asbestos
  publication-title: Radiology
– volume: 4
  start-page: 272
  year: 1998
  end-page: 280
  ident: bib11
  article-title: Exercise and interstitial lung disease
  publication-title: Curr Opin Pulm Med
– volume: 102
  start-page: 1675
  year: 2008
  end-page: 1680
  ident: bib10
  article-title: Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation
  publication-title: Respir Med
– volume: 103
  start-page: 1430
  year: 2009
  end-page: 1435
  ident: bib13
  article-title: Small changes in six-minute walk distance are important in diffuse parenchymal lung disease
  publication-title: Respir Med
– volume: 51
  start-page: 1173
  year: 1986
  end-page: 1182
  ident: bib27
  article-title: The moderator–mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations
  publication-title: J Pers Soc Psychol
– volume: 10
  start-page: 407
  year: 1989
  end-page: 415
  ident: bib17
  article-title: Measurement of health status. Ascertaining the minimal clinically important difference
  publication-title: Control Clin Trials
– volume: 43
  start-page: 708
  year: 1988
  end-page: 714
  ident: bib6
  article-title: Functional similarities of asbestosis and cryptogenic fibrosing alveolitis
  publication-title: Thorax
– volume: 1
  start-page: 510
  year: 1988
  end-page: 516
  ident: bib28
  article-title: Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis
  publication-title: Eur Respir J
– volume: 16
  start-page: 1196
  year: 2011
  end-page: 1202
  ident: bib24
  article-title: Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
  publication-title: Respirology
– volume: 81
  start-page: 196
  year: 2011
  end-page: 205
  ident: bib22
  article-title: Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
  publication-title: Respiration
– volume: 103
  start-page: 1430
  year: 2009
  ident: 10.1016/j.rmed.2011.11.014_bib13
  article-title: Small changes in six-minute walk distance are important in diffuse parenchymal lung disease
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2009.04.024
– volume: 173
  start-page: 1390
  year: 2006
  ident: 10.1016/j.rmed.2011.11.014_bib29
  article-title: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200508-1211ST
– volume: 63
  start-page: 549
  year: 2008
  ident: 10.1016/j.rmed.2011.11.014_bib1
  article-title: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease
  publication-title: Thorax
  doi: 10.1136/thx.2007.088070
– volume: 183
  start-page: 788
  year: 2011
  ident: 10.1016/j.rmed.2011.11.014_bib25
  article-title: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.2009-040GL
– volume: 137
  start-page: 273
  year: 2010
  ident: 10.1016/j.rmed.2011.11.014_bib23
  article-title: Effects of pulmonary rehabilitation in patients with restrictive lung diseases
  publication-title: Chest
  doi: 10.1378/chest.09-0241
– year: 2008
  ident: 10.1016/j.rmed.2011.11.014_bib5
  article-title: Physical training for interstitial lung disease
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD006322.pub2
– volume: 168
  start-page: 1084
  year: 2003
  ident: 10.1016/j.rmed.2011.11.014_bib26
  article-title: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200302-219OC
– volume: 51
  start-page: 1173
  year: 1986
  ident: 10.1016/j.rmed.2011.11.014_bib27
  article-title: The moderator–mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations
  publication-title: J Pers Soc Psychol
  doi: 10.1037/0022-3514.51.6.1173
– year: 2006
  ident: 10.1016/j.rmed.2011.11.014_bib3
  article-title: Pulmonary rehabilitation for chronic obstructive pulmonary disease
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD003793.pub2
– volume: 101
  start-page: 2011
  year: 2007
  ident: 10.1016/j.rmed.2011.11.014_bib4
  article-title: Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2007.03.012
– volume: 1
  start-page: 510
  year: 1988
  ident: 10.1016/j.rmed.2011.11.014_bib28
  article-title: Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis
  publication-title: Eur Respir J
  doi: 10.1183/09031936.93.01060510
– volume: 131
  start-page: 650
  year: 2007
  ident: 10.1016/j.rmed.2011.11.014_bib19
  article-title: Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
  publication-title: Chest
  doi: 10.1378/chest.06-1466
– volume: 135
  start-page: 442
  year: 2009
  ident: 10.1016/j.rmed.2011.11.014_bib21
  article-title: Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response
  publication-title: Chest
  doi: 10.1378/chest.08-1458
– volume: 13
  start-page: 394
  year: 2008
  ident: 10.1016/j.rmed.2011.11.014_bib2
  article-title: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2007.01205.x
– volume: 174
  start-page: 803
  year: 2006
  ident: 10.1016/j.rmed.2011.11.014_bib20
  article-title: Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200604-488OC
– volume: 167
  start-page: 962
  year: 2003
  ident: 10.1016/j.rmed.2011.11.014_bib18
  article-title: Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.2111053
– volume: 63
  start-page: v1
  issue: Suppl. 5
  year: 2008
  ident: 10.1016/j.rmed.2011.11.014_bib30
  article-title: Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society
  publication-title: Thorax
– volume: 232
  start-page: 66
  year: 2004
  ident: 10.1016/j.rmed.2011.11.014_bib8
  article-title: Thin-section CT abnormalities and pulmonary gas exchange impairment in workers exposed to asbestos
  publication-title: Radiology
  doi: 10.1148/radiol.2321030392
– volume: 102
  start-page: 1675
  year: 2008
  ident: 10.1016/j.rmed.2011.11.014_bib10
  article-title: Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2008.08.014
– volume: 4
  start-page: 272
  year: 1998
  ident: 10.1016/j.rmed.2011.11.014_bib11
  article-title: Exercise and interstitial lung disease
  publication-title: Curr Opin Pulm Med
  doi: 10.1097/00063198-199809000-00006
– volume: 16
  start-page: 1196
  year: 2011
  ident: 10.1016/j.rmed.2011.11.014_bib24
  article-title: Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2011.02029.x
– volume: 43
  start-page: 708
  year: 1988
  ident: 10.1016/j.rmed.2011.11.014_bib6
  article-title: Functional similarities of asbestosis and cryptogenic fibrosing alveolitis
  publication-title: Thorax
  doi: 10.1136/thx.43.9.708
– volume: 116
  start-page: 1175
  year: 1999
  ident: 10.1016/j.rmed.2011.11.014_bib16
  article-title: Assessment of health-related quality of life in patients with interstitial lung disease
  publication-title: Chest
  doi: 10.1378/chest.116.5.1175
– volume: 25
  start-page: 96
  year: 2005
  ident: 10.1016/j.rmed.2011.11.014_bib15
  article-title: The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
  publication-title: Eur Respir J
  doi: 10.1183/09031936.04.00137203
– volume: 166
  start-page: 111
  year: 2002
  ident: 10.1016/j.rmed.2011.11.014_bib14
  article-title: ATS statement: guidelines for the six-minute walk test
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.166.1.at1102
– volume: 60
  start-page: 201
  year: 2003
  ident: 10.1016/j.rmed.2011.11.014_bib7
  article-title: Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis
  publication-title: Occup Environ Med
  doi: 10.1136/oem.60.3.201
– volume: 63
  start-page: v1
  year: 2008
  ident: 10.1016/j.rmed.2011.11.014_bib9
  article-title: Interstitial lung disease guideline
  publication-title: Thorax
  doi: 10.1136/thx.2008.101691
– volume: 10
  start-page: 407
  year: 1989
  ident: 10.1016/j.rmed.2011.11.014_bib17
  article-title: Measurement of health status. Ascertaining the minimal clinically important difference
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(89)90005-6
– volume: 161
  start-page: 646
  year: 2000
  ident: 10.1016/j.rmed.2011.11.014_bib12
  article-title: Diagnosis and treatment. International consensus statement
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.161.2.ats3-00
– volume: 81
  start-page: 196
  year: 2011
  ident: 10.1016/j.rmed.2011.11.014_bib22
  article-title: Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
  publication-title: Respiration
  doi: 10.1159/000315475
SSID ssj0009440
Score 2.364279
Snippet Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes...
Summary Background Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 429
SubjectTerms Aged
Biological and medical sciences
Clinical trials
Diet
Disease
Dyspnea - etiology
Dyspnea - physiopathology
Dyspnea - rehabilitation
Dyspnoea
Exercise
Exercise Test - methods
Follow-Up Studies
Humans
Idiopathic Pulmonary Fibrosis - physiopathology
Idiopathic Pulmonary Fibrosis - rehabilitation
Interstitial
Lung diseases
Lung Diseases, Interstitial - etiology
Lung Diseases, Interstitial - physiopathology
Lung Diseases, Interstitial - rehabilitation
Medical sciences
Middle Aged
Miscellaneous
Noncitizens
Oxygen - blood
Oxyhemoglobins - metabolism
Partial Pressure
Pneumology
Prognosis
Pulmonary fibrosis
Pulmonary/Respiratory
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Respiratory system : syndromes and miscellaneous diseases
Severity of Illness Index
Treatment Outcome
Vital Capacity - physiology
Walking - physiology
Title Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0954611111004355
https://www.clinicalkey.es/playcontent/1-s2.0-S0954611111004355
https://dx.doi.org/10.1016/j.rmed.2011.11.014
https://www.ncbi.nlm.nih.gov/pubmed/22182340
https://www.proquest.com/docview/1035137652
https://www.proquest.com/docview/1027985717
https://www.proquest.com/docview/1095452227
https://www.proquest.com/docview/916696700
Volume 106
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OE0Q4xO-L3pUVfJPY7GY_ksfz8KiKh6AnfVuSzQYqpS1pi_ji3-5Msmkp2h74lo_ZZDOZ-c0sOx8ArxNRlFmeVLF0qG7SexkXKqWM5VTWeVVx79poi2s9upEfx2p8BJd9LgyFVQbs7zC9RetwZRi4OVxMJsOv6BxITRpPRc_QbCIOU1YpJfGN320L78o2KZKIY6IOiTNdjFeDFqcr40mVPLncZ5xOFsUSWVZ3vS72O6OtUbp6CA-CN8kuugk_giM_ewz3Pof98ifw_UtDx9RRh81rViKw1ZMVq_Hnz3-i0WKL9RTlsGh-sWanZDeSNIxKSTQUS4AyyqaICixs5zyFm6v33y5HceikEDudq1UsVOl56USmRJ14bkzutEfOeK695y6tshT1Nsu8Mbp2PtWVr4Q2SaF05dBBSp_B8Ww-86fAMqo5JlNTIGLLkhd5oURpanyOyzwiRgS8Z6F1Yc7U7WJq-3iyH5bYbontuP6wyPYI3mzGLLoiGwep0_7P2D59FAHPog04OMr8a5RfBp1dWm6Xwib2L7mKQG1G7ojmrW8c7IjN5tNwFWfID43grJcju50Fbe0i6isRwavNbdR52sgpZn6-Jhph8kzhSvwQTU7t44VAGraHBpcGOqc8rQied2K8nSNV9k9l8uI_P_4l3Mcz0UXrncHxqln7c3TfVuUA7rz9zQdw9-LDp9H1oNXWP2knRAM
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OE1QQ8fui57mCbxKa3exH8qiHR0_vDsE76duSbDZQKW1JWw7_e2eSTUvRVvAtJLPJ7mS-lp35DcD7RBRllidVLB2qm_RexoVKqWI5lXVeVdy7NtviSg9v5JeRGh3AaV8LQ2mVwfZ3Nr211uHOIHBzMB-PB98xOJCaNJ5Az9Bt3oG7GA1oAtA_H33aIO_KtiqSqGMiD5UzXZJXgy6nw_EkKE8ud3mnh_NigTyru2YXu6PR1iudPYZHIZxkH7sZP4EDP30K9y7Dgfkz-PGtoWtqqcNmNSvRstXjJavx789u0Wux-WqCglg0v1izhdmNJA0jLImGkglQSNkEzQIL5znP4ebs8_XpMA6tFGKnc7WMhSo9L53IlKgTz43JnfbIGc-199ylVZai4maZN0bXzqe68pXQJimUrhxGSOkLOJzOpv4IWEagYzI1BZpsWfIiL5QoTY3vcZlHkxEB71loXZgztbuY2D6h7KcltltiO25ALLI9gg_rMfMOZWMvddr_GdvXj6LFs-gE9o4yfxvlF0FpF5bbhbCJ_UOwIlDrkVuy-c8vnmyJzXppuI0zFIhGcNzLkd3Mgs520ewrEcG79WNUejrJKaZ-tiIaYfJM4VZ8H01O_eOFQBq2gwb3BjqnQq0IXnZivJkjQfunMnn1n4t_C_eH15cX9uL86utreIBPRJe6dwyHy2bl32AstyxPWl39DfDWRJs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+of+benefit+following+pulmonary+rehabilitation+for+interstitial+lung+disease&rft.jtitle=Respiratory+medicine&rft.au=Holland%2C+Anne+E.&rft.au=Hill%2C+Catherine+J.&rft.au=Glaspole%2C+Ian&rft.au=Goh%2C+Nicole&rft.date=2012-03-01&rft.issn=0954-6111&rft.volume=106&rft.issue=3&rft.spage=429&rft.epage=435&rft_id=info:doi/10.1016%2Fj.rmed.2011.11.014&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_rmed_2011_11_014
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09546111%2FS0954611112X00027%2Fcov150h.gif